We are proud to offer MK-2866 in a bottle of 90 capsules with 15mg per capsule.
MK-2866 is a selective androgen receptor modulator (SARM) that has gained significant attention for its potential anabolic effects on muscle tissue. It has been studied extensively for its ability to promote muscle growth and improve physical performance without the unwanted androgenic side effects associated with traditional anabolic steroids. This article aims to provide an overview of the mechanism of action of MK-2866 and summarize key findings from in vitro and in vivo studies.
Mechanism of Action:
MK-2866 selectively targets and binds to androgen receptors in skeletal muscle and bone tissues, leading to its anabolic effects. Unlike traditional anabolic steroids, MK-2866 exhibits tissue-selective activity, meaning it primarily affects the desired tissues while minimizing side effects in other organs .
Once bound to androgen receptors, MK-2866 activates androgen receptor signaling pathways, resulting in increased protein synthesis and muscle fiber hypertrophy. This leads to the growth and development of skeletal muscle tissue, ultimately enhancing muscle strength and performance. Importantly, MK-2866’s tissue-selective activity allows it to exert its anabolic effects specifically in skeletal muscle, while minimizing adverse effects on other tissues .
In Vitro Studies:
In vitro studies have provided insights into the cellular mechanisms underlying the effects of MK-2866. These studies have shown that MK-2866 stimulates protein synthesis in muscle cells, leading to increased muscle mass. It has also been observed to enhance muscle cell differentiation, promoting the formation of mature muscle fibers.
MK-2866’s effects on muscle growth and differentiation are mediated by its interaction with androgen receptors. By activating androgen receptor signaling, MK-2866 initiates a cascade of cellular events that lead to increased protein synthesis, muscle fiber hypertrophy, and improved muscle function.
Additionally, MK-2866 has demonstrated effects on bone tissue in vitro. It promotes bone mineralization by stimulating osteoblastic activity, the cells responsible for bone formation. This can contribute to increased bone mineral density and improved bone strength .
In Vivo Studies:
Animal studies have been conducted to evaluate the in vivo effects of MK-2866 on muscle mass, strength, and physical performance. These studies consistently demonstrate MK-2866’s anabolic properties without the undesirable androgenic side effects associated with traditional anabolic steroids.
In models of muscle wasting conditions, MK-2866 has shown the ability to prevent muscle loss and increase lean body mass. These studies have also revealed improvements in muscle strength and function, suggesting that MK-2866 may have therapeutic potential for muscle wasting diseases.
Furthermore, MK-2866 has been found to enhance exercise performance and endurance in animal models. It improves running endurance, grip strength, and recovery from muscle damage, indicating its potential as an ergogenic aid for athletes and individuals seeking to enhance physical performance .
MK-2866 and Bone Health:
Studies have investigated the effects of MK-2866 on bone health, demonstrating its potential benefits in this area. Animal studies have shown that MK-2866 increases bone mineral density and improves bone strength. These effects are attributed to MK-2866’s ability to stimulate osteoblastic activity and enhance bone formation, while suppressing osteoclastogenesis, the process of bone resorption.
The positive impact of MK-2866 on bone health suggests potential applications for conditions such as osteoporosis, osteopenia, and age-related bone loss .
Safety and Side Effects:
MK-2866 has generally shown a good safety profile in preclinical and clinical studies. It exhibits tissue-selective activity, which reduces the likelihood of androgenic side effects such as virilization and suppression of natural testosterone production. However, like any pharmaceutical compound, MK-2866 is not without potential side effects, and further research is needed to establish its long-term safety profile .
MK-2866 (Ostarine) is a selective androgen receptor modulator that has gained attention for its potential anabolic effects on muscle tissue. It selectively targets androgen receptors in skeletal muscle and bone tissues, leading to increased protein synthesis, muscle fiber hypertrophy, and improved muscle strength and performance. In vitro studies have shown that MK-2866 stimulates protein synthesis and muscle cell differentiation, while also promoting bone mineralization.
WARNING: This product is intended for research purposes only. The research chemical designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
- Dong L, Sun L, Hu X, et al. Ostarine attenuates pyocyanin in Pseudomonas aeruginosa by interfering with quorum sensing systems. J Antibiot (Tokyo). 2021;74(12):863-873. doi:10.1038/s41429-021-00469-4
- Lambert CP. Should the FDA’s criteria for the clinical efficacy of cachexia drugs be changed? Is Ostarine safe and effective?. J Cachexia Sarcopenia Muscle. 2021;12(3):531-532. doi:10.1002/jcsm.12695
- Furuya K. Clin Calcium. 2010;20(2):225-233.
- Girgis CM, Mokbel N, Digirolamo DJ. Therapies for musculoskeletal disease: can we treat two birds with one stone?. Curr Osteoporos Rep. 2014;12(2):142-153. doi:10.1007/s11914-014-0204-5
- Komrakova M, Furtwängler J, Hoffmann DB, Lehmann W, Schilling AF, Sehmisch S. The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats. Calcif Tissue Int. 2020;106(2):147-157. doi:10.1007/s00223-019-00613-1
- Yuan Y, Lee JS, Yost SE, et al. A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer. Oncologist. 2021;26(2):99-e217. doi:10.1002/onco.13583
Submit your review